Medifast (MED) Return on Capital Employed (2011 - 2026)

Medifast's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 7.82% for Q1 2026.

• Quarterly Return on Capital Employed fell 496.0% year-over-year to 7.82% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.82% (down 496.0% YoY) and the FY2025 annual result came in at 6.37%, down 761.0% from the prior year.
• Return on Capital Employed was 7.82% for Q1 2026 at Medifast, down from 6.61% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 111.08% in Q3 2022 and bottomed at 7.82% in Q1 2026.
• A 5-year average of 44.93% and a median of 35.27% in 2024 frame the typical range for Return on Capital Employed.
• Annual changes were most pronounced in 2022 — Return on Capital Employed jumped 1084 bps — and 2024, when it sank 6890 bps.
• Medifast's Return on Capital Employed stood at 102.45% in 2022, then plunged by 45 bps to 56.77% in 2023, then plunged by 98 bps to 1.29% in 2024, then plunged by 613 bps to 6.61% in 2025, then dropped by 18 bps to 7.82% in 2026.
• Business Quant data shows MED's Return on Capital Employed at 7.82% in Q1 2026, 6.61% in Q4 2025, and 2.57% in Q3 2025.